Universal Ibogaine (TSXV:IBO) ROCE %: -4.66% (As of Apr. 2025)


What is Universal Ibogaine ROCE %?

Universal Ibogaine TSXV:IBO ROCE % is -4.66% as of Apr. 2025.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Universal Ibogaine's annualized ROCE % for the quarter that ended in Apr. 2025 was -4.66%.

Universal Ibogaine  (TSXV:IBO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Universal Ibogaine ROCE % Related Terms

Universal Ibogaine ROCE % Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine ROCE % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
ROCE %
Get a 7-Day Free Trial -40.41 -101.99 -499.07 -66.46 -60.46

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -76.32 -74.29 -36.76 -36.02 -4.66

Universal Ibogaine ROCE % Calculation

Universal Ibogaine's annualized ROCE % for the fiscal year that ended in Jul. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2024 )  (A: Jul. 2023 )(A: Jul. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2024 )  (A: Jul. 2023 )(A: Jul. 2024 )
=-1.883/( ( (5.502 - 2.788) + (4.513 - 0.998) )/ 2 )
=-1.883/( (2.714+3.515)/ 2 )
=-1.883/3.1145
=-60.46 %

Universal Ibogaine's ROCE % of for the quarter that ended in Apr. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2025 )  (Q: Jan. 2025 )(Q: Apr. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2025 )  (Q: Jan. 2025 )(Q: Apr. 2025 )
=-0.112/( ( (3.783 - 0.974) + (4.007 - 2.012) )/ 2 )
=-0.112/( ( 2.809 + 1.995 )/ 2 )
=-0.112/2.402
=-4.66 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -4.66% mean?
Universal Ibogaine (TSXV:IBO) has a ROCE % of -4.66% as of Apr. 2025.
Is Universal Ibogaine's ROCE % too high?
Universal Ibogaine's current ROCE % is -4.66%.
How does Universal Ibogaine's ROCE % compare to LABT and CALC?
Universal Ibogaine's ROCE % of -4.66% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Universal Ibogaine's current ROCE % is -4.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (TSXV:IBO) has a current ROCE % of -4.66%. The current ROCE % is -4.66%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Universal Ibogaine (TSXV:IBO), the current ROCE % is -4.66% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.